Document and Entity Information
Document and Entity Information | Dec. 01, 2023 |
Document Type | 8-K |
Document Period End Date | Dec. 01, 2023 |
Entity Registrant Name | Ambrx Biopharma, Inc. |
Entity Incorporation, State or Country Code | DE |
Securities Act File Number | 000-56600 |
Entity Tax Identification Number | 93-2892120 |
Entity Address, Address Line One | 10975 North Torrey Pines Road |
Entity Address, City or Town | La Jolla |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92037 |
City Area Code | 858 |
Local Phone Number | 875-2400 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Amendment Flag | false |
Entity Central Index Key | 0001990550 |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Security Exchange Name | NASDAQ |
Trading Symbol | AMAM |